We are excited to announce our first STORZ MEDICAL live webinar on Tuesday, 14th April 2020 at 18:00. Prof. Dr. Karsten Knobloch will talk about the history of shock wave therapy – as it‘s been 40 years now since the first successful clinical application of shock wave lithotripsy (SWL) for kidney stone disintegration in February 1980 in Munich, Germany.

Safety comes first – in all areas

Due to the worsening COVID 19 pandemic, STORZ MEDICAL has taken a number of measures to protect our employees, customers and partners in the best possible way and to ensure business operations. We are guided by the recommendations of international and national authorities.

In February 2020, STORZ MEDICAL has received the CE approval for the MAGNETOLITH® system, which is the successor of the CELLACTOR® MT1. Extracorporeal Magnetotransduction Therapy (EMTT®) with the MAGNETOLITH® opens up new possibilities in regeneration and rehabilitation. The areas of application include diseases of the musculoskeletal system such as lower back pain and tendinopathies of the rotator cuff or Achilles tendon. The non-invasive, outpatient therapy is virtually free of side effects.

40 years ago, on 7 February 1980, the first treatment of a kidney stone patient with shock waves was performed at the Department of Urology of Munich University Hospital based at the Grosshardern campus. Several STORZ MEDICAL employees from the company’s research, development and marketing departments were present to witness the historic event, which ushered in a new era in medical technology: the era of extracorporeal shock wave lithotripsy (ESWL).

For years, STORZ MEDICAL has been teaming up with medical specialists to pioneer the development of radial shock wave transmitters, which are used to treat myofascial conditions. One of the challenges that medical professionals face every day when using shock waves is ensuring that treatment of particularly sensitive and deep-lying trigger points and myofascial imbalances is gentle, effective and virtually pain-free.